• Daily Marijuana Observer Facebook
  • Daily Marijuana Observer Twitter
  • Daily Marijuana Observer StockTwits
  • Daily Marijuana Observer SA
  • Daily Marijuana Observer Instagram
  • Daily Marijuana Observer Youtube
  • Pinterest Social Icon
  • Daily Marijuana Observer Talk Market

Long-Term Study on MMJ's Impact on Opioid Use Awarded Grant From NIH

August 8, 2017

 

Researchers at the Albert Einstein College of Medicine and the Montefiore Health System based in The Bronx, NY have been awarded a $3.8 million grant from the National Institutes of Health (NIH) to conduct the first long term study on the effects of medical marijuana on opioid use in adults with chronic pain, including HIV+ individuals. 

 

 

The principal investigator on the grant, and associate chief of general internal medicine at Einstein and Montefiore, Chinazo Cunningham, M.D., M.S. had this to say about the study and grant: 

 

"There is a lack of information about the impact of medical marijuana on opioid use in those with chronic pain. We hope this study will fill in the gaps and provide doctors and patients with some much needed guidance." 

 

Never before have researchers studied if over time the use of medical marijuana reduces the use of opioids. That said, a recent study did note a correlation between the legalization of medical marijuana and decreases in both the hospitalization rates of people suffering from opioid abuse and cases of opioid overdose.

 

About the Study 

 

The study will enroll 250 adults (both HIV+ and HIV-) with chronic pain that use opioids and have received a medical marijuana certification from their physician.

 

Related: How Marijuana Helps HIV Patients With Treatment

 

Over the course of 18 months, study participants will complete a web-based questionnaire every two weeks that focuses on pain levels and the medicinal and illicit use of marijuana and opioids. Every three months, study participants will provide urine and blood samples, and a select group will be interviewed regarding their perceptions of how medical marijuana use affects the use of opioids. 

 

Conclusion

 

Be sure to subscribe to one or more of our free e-mail newsletters so you never miss an important cannabis update. Also, be sure to connect with The Daily Marijuana Observer on social media via FacebookTwitter, Instagram and Pinterest

 

D/M/O

Please reload

LATEST NEWS
Please reload

Please reload

DMO

© Copyright 2016-2020 Smoke Show Ventures, Inc.

RSS Feed

Disclaimer: Except for the historical information and data presented herein, matters discussed in articles on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future performance or achievements expressed or implied by such coverage. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. Before making specific investment decisions, readers should seek their own professional advice and that of their own professional financial adviser. Smoke Show Ventures, Inc. or its affiliates, which owns The Daily Marijuana Observer, may be compensated for its services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.dailymarijuanaobserver.com/legal-disclaimer/.